milvexian
bms
['axiomatic', 'fxi']
fantastic session at esc presenting the results of this exciting dose finding trial of fxia inhibition-axiomatic ssp. excellent safety on top of dual anti platelet therapy with first dose within 48 hours of symptom onset of tia or ischemic stroke. 
Stroke Neurologist McMaster/PHRI Clinical trialist working on stroke prevention